BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+10.14%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$690M
AUM Growth
+$690M
(-3.2%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
57.65%
Holding
63
New
10
Increased
12
Reduced
21
Closed
11
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$16.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$14.5M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$14.1M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$12.3M |
| 5 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$11.7M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$19M |
| 2 |
ADXS
Advaxis, Inc.
ADXS
|
$12.4M |
| 3 |
MDCO
Medicines Co
MDCO
|
$10.5M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$9.14M |
| 5 |
DURECT Corp
DRRX
|
$8.93M |
Sector Composition
| 1 | Healthcare | 89.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SCYNEXIS
SCYX
$34.9M
| – | – | -1,477,273 | Closed | -$4.08M |
|
|
VXRT
52
DELISTED
Vaxart
VXRT
| – | – | -3,179,226 | Closed | -$2.07M |
|
53
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
AVGR
54
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – | -500,000 | Closed | -$950K |
|
|
SPNE
55
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| – | – | -1,099,807 | Closed | -$8.63M |
|
|
ADXS
56
DELISTED
Advaxis, Inc.
ADXS
| – | – | -1,519,259 | Closed | -$12.4M |
|
|
GNMX
57
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| – | – | 0 | – | – |
|
|
MDCO
58
DELISTED
Medicines Co
MDCO
| – | – | -215,077 | Closed | -$10.5M |
|
|
WINT
59
DELISTED
Windtree Therapeutics Inc
WINT
| – | – | -777,797 | Closed | -$887K |
|
|
OMED
60
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| – | – | 0 | – | – |
|
|
BCR
61
DELISTED
CR Bard Inc.
BCR
| – | – | -27,300 | Closed | -$6.79M |
|